Patients with moderate asthma ( age 12 years ; pre-bronchodilator forced expiratory volume in 1 second ( FEV1 ) 40-85 % predicted ; FEV1 reversibility of 12 % and 200 ml ) were randomized to FF or fluticasone propionate ( FP ) regimens in a double-blind , crossover study .
